Schneider, M.A.; Muley, T.; Weber, R.; Wessels, S.; Thomas, M.; Herth, F.J.F.; Kahn, N.C.; Eberhardt, R.; Winter, H.; Heussel, G.;
et al. Glycodelin as a Serum and Tissue Biomarker for Metastatic and Advanced NSCLC. Cancers 2018, 10, 486.
https://doi.org/10.3390/cancers10120486
AMA Style
Schneider MA, Muley T, Weber R, Wessels S, Thomas M, Herth FJF, Kahn NC, Eberhardt R, Winter H, Heussel G,
et al. Glycodelin as a Serum and Tissue Biomarker for Metastatic and Advanced NSCLC. Cancers. 2018; 10(12):486.
https://doi.org/10.3390/cancers10120486
Chicago/Turabian Style
Schneider, Marc A., Thomas Muley, Rebecca Weber, Sabine Wessels, Michael Thomas, Felix J. F. Herth, Nicolas C. Kahn, Ralf Eberhardt, Hauke Winter, Gudula Heussel,
and et al. 2018. "Glycodelin as a Serum and Tissue Biomarker for Metastatic and Advanced NSCLC" Cancers 10, no. 12: 486.
https://doi.org/10.3390/cancers10120486
APA Style
Schneider, M. A., Muley, T., Weber, R., Wessels, S., Thomas, M., Herth, F. J. F., Kahn, N. C., Eberhardt, R., Winter, H., Heussel, G., Warth, A., Herold-Mende, C., & Meister, M.
(2018). Glycodelin as a Serum and Tissue Biomarker for Metastatic and Advanced NSCLC. Cancers, 10(12), 486.
https://doi.org/10.3390/cancers10120486